Is a complete IDX/HEAL research report available?

No complete published report is available for idx/HEAL (IDX/HEAL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

idx/HEAL stock profile: metrics, valuation and analysis

Market cap	10.3T
Revenue (ttm)	7.4T
Net income (ttm)	397.9B
EPS (ttm)	IDR 25.9
Shares out	15.2B
P/E (trailing)	26.0x
P/E (forward)	20.0x
Dividend	IDR 10.5 (1.53%)
Volume	13,598,700
Beta	-0.20

All IDX/HEAL indicators

Market & fundamental data

Available fields

232

Groups with data

Currency

IDR

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Indonesia
Country code	ID
Employees	19,235
Employees Change	973%
Employees Change Percent	5.33
Enterprise value	IDR 14.9T
Exchange	Indonesia Stock Exchange
Financial currency	IDR
First seen	2026-05-10
Industry	Medical Care Facilities
Industry PE	71.53
Industry PE Fwd	17.68
Isin	ID1000143100
Last refreshed	2026-09-12
Market cap	IDR 10.3T
Price	IDR 675
Price currency	IDR
Rev Per Employee	382,343,956.33x
Sector	Healthcare
Sector PE	36.24
Sector PE Fwd	13.19
Sic	8062
Symbol	idx/HEAL
Website	https://www.herminahospitals.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.87%
EV Earnings	37.55x
EV/EBIT	15.97x
EV/EBITDA	8.38x
EV/Sales	2.03x
FCF yield	-3.34%
Forward P/E	19.95x
P/B ratio	1.45x
P/E ratio	26.02x
P/S ratio	1.4x
PE Ratio10 Y	44.9x
PE Ratio3 Y	43.88x
PE Ratio5 Y	43.27x
PEG ratio	1.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	12.72%
EBITDA Margin	24.06%
Gross margin	31.41%
Gross Profit	IDR 2.3T
Gross Profit Growth	4.12%
Gross Profit Growth Q	6.11%
Gross Profit Growth3 Y	12.23%
Gross Profit Growth5 Y	-4.18%
Net Income	IDR 397.9B
Net Income Growth	-4.73%
Net Income Growth Q	-8.19%
Net Income Growth Qo Q	-9.23%
Net Income Growth Years	0%
Net Income Growth3 Y	5.74%
Net Income Growth5 Y	-15.32%
Pretax Margin	9.79%
Profit Margin	5.41%
Profit Per Employee	IDR 20.7M
Profitable Quarters	IDR 38
Profitable Years	11
ROA	4.89
Roa5y	7.83
ROCE	9.14
ROE	7.28
Roe5y	14.7
ROIC	6.64
Roic5y	13.87

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-59.95%
Cagr3y	-21.98%
Cagr5y	-10.81%
Div CAGR3	24.47%
Div CAGR5	21.98%
EPS Growth	-7.56
EPS Growth Q	-13.46
EPS Growth Qo Q	-8.7
EPS Growth Years	0
EPS Growth3 Y	4.3
EPS Growth5 Y	-15.91
OCF Growth	14.6%
OCF Growth Q	20.47%
OCF Growth Qo Q	9.11%
OCF Growth3 Y	3.84%
OCF Growth5 Y	5.36%
Revenue Growth	8.77x
Revenue Growth Q	7.67x
Revenue Growth Qo Q	2.41x
Revenue Growth Quarters	5x
Revenue Growth Years	3x
Revenue Growth3 Y	12.04x
Revenue Growth5 Y	4.93x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	IDR 0.62
Assets	IDR 12T
Cash	IDR 571.8B
Current Assets	IDR 2.2T
Current Liabilities	IDR 1.8T
Debt	IDR 3.6T
Debt EBITDA	IDR 2.04
Debt Equity	IDR 0.51
Debt FCF	IDR -10.58
Equity	IDR 7.1T
Interest Coverage	4.06
Liabilities	IDR 4.9T
Long Term Assets	IDR 9.8T
Long Term Liabilities	IDR 3.1T
Net Cash	IDR -3.1T
Net Cash By Market Cap	IDR -29.8
Net Debt EBITDA	IDR 1.73
Net Debt Equity	IDR 0.43
Tangible Book Value	IDR 5.5T
Tangible Book Value Per Share	IDR 360
WACC	3.52

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.27
Inventory Turnover	39.21
Net Working Capital	IDR 507.5B
Quick ratio	1.17
Working Capital	IDR 474.4B
Working Capital Turnover	IDR 8.52

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.06%
Dividend Growth	28.57%
Dividend Growth Years	6%
Dividend per share	IDR 10.5
Dividend Years	8
Dividend Yield	1.53%
Ex Div Date	2026-05-05
Last Dividend	IDR 13.5
Payout Frequency	Annual
Payout Ratio	51.73%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-59.92%
200-day SMA	1,119.7
3Y total return	-52.51%
50-day SMA	774.2
50-day SMA vs 200-day SMA	50under200
5Y total return	-43.54%
All Time High	1,800
All Time High Change	-62.5%
All Time High Date	2023-01-09
All Time Low	370
All Time Low Change	82.43%
All Time Low Date	2020-03-24
ATR	28.44
Beta	-0.2
Beta1y	-0.04
Beta2y	0.24
Ch YTD	-50.91
High	685
High52	1,750
High52 Date	2025-09-15
High52ch	-61.43%
Low	660
Low52	630
Low52 Date	2026-08-27
Low52ch	7.14%
Ma50ch	-12.81%
Price vs 200-day SMA	-39.71%
RSI	38.94
RSI Monthly	30.6
RSI Weekly	22.8
Sharpe ratio	-2.3x
Sharpe Ratio3y	-0.56x
Sharpe Ratio5y	-0.09x
Sortino ratio	-2.9
Sortino Ratio3y	-0.67
Sortino Ratio5y	0.05
Total Return	-1.53%
Tr YTD	-50.3
Tr1m	-13.46%
Tr1w	-1.46%
Tr3m	-20.59%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	8,040,500,896%
Net Borrowing	22,023,000,000
Shares Insiders	26.92%
Shares Institutions	3.19%
Shares Out	15,245,698,700
Shares Qo Q	-0.58%
Shares Yo Y	3.06%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	30,004,800x
Bv Per Share	361.7
CAPEX	IDR -1.6T
Ch1m	-13.46
Ch1w	-1.46
Ch1y	-60.41
Ch3m	-20.59
Ch3y	-53.77
Ch5y	-45.56
Ch6m	-47.88
Change	0%
Change From Open	0
Close	675
Days Gap	0
Depreciation Amortization	833,662,000,000
Dollar Volume	9,179,122,500
Earnings Date	2026-10-22
EBIT	IDR 935.7B
EBITDA	IDR 1.8T
EPS	IDR 25.94
F Score	5
FCF	IDR -343.8B
FCF EV Yield	-2.3x
FCF Per Share	IDR -22.55
Financing CF	-361,440,000,000
Fiscal Year End	December
Founded	1,985
Graham Number	459.45382
Graham Upside	-31.93
Income Tax	IDR 206.5B
Investing CF	-1,690,342,000,000
Is Primary Listing	1
Last Earnings Date	2025-10-30
Last Report Date	2026-06-30
Last Split Date	2021-07-30
Last Split Type	Forward
Lynch Fair Value	IDR 130
Lynch Upside	-80.79
Ma150	1,019.6
Ma150ch	-33.8%
Ma20	678.5
Ma20ch	-0.52%
Net CF	-843,440,000,000
Next Earnings Date	2026-10-22
Open	675
P OCF Ratio	8.52
Payment Date	2026-05-22
Position In Range	60
Ppne	8,411,558,000,000
Price Date	2026-09-11
Price EBITDA	IDR 5.82
Ptbv Ratio	1.87
Relative Volume	0.45x
Revenue	7,354,386,000,000x
Tax By Revenue	2.81x
Tax Rate	28.68%
Tr6m	-47.23%
Volume	13,598,700
Z Score	3.87

IDX/HEAL (IDX/HEAL)

Price

Financial snapshot

Fair-value bridge

Latest news · IDX/HEAL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IDX/HEAL indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on IDX/HEAL

Frequently asked questions